Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma

Journal of Neurosurgery

Volumn 98, Issue 2, 2003, Pages 269-276

  Galanaud, Damien ^a   Chinot, Olivier ^a   Nicoli, François ^a   Confort Gouny, Sylviane ^a   Fur, Yann Le ^a   Barrié Attarian, Maryline ^a   Ranjeva, Jean Philippe ^a   Fuentès, Stéphane ^a   Viout, Patrick ^a   Figarella Branger, Dominique ^a   Cozzone, Patrick J ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b University of Aix Marseille   (France)

Author keywords

Brain neoplasm; Glioma; Gliomatosis cerebri; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CANCER GRADING; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIA; GLIOMA; GLIOMATOSIS CEREBRI; GLIOSIS; HUMAN; MALE; NERVE CELL LESION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0037306784     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.2.0269     Document Type: Article

References (31)

1. Bendszus M, Warmuth-Metz M, Klein R, et al: MR spectroscopy in GC. AJNR 21:375-380, 2000
2. Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298, 1993
3. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013-2021, 1994
4. Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR 21:1645-1649, 2000
5. Chang L, Emst T, Osborn D, et al: Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 55:305-311, 1998
6. Cheng LL, Chang IW, Louis DN, et al: Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58:1825-1832, 1998
7. Confort-Gouny S, Vion-Dury J, Nicoli F, et al: A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118:123-133, 1993
8. Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 24:504-511, 1974
9. del Carpio-O'Donovan R, Korah I, Salazar A, et al: Gliomatosis cerebri. Radiology 198:831-835, 1996
10. Essig M, Schlemmer HP, Tronnier V, et al: Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri. Eur Radiol 11:303-308, 2001
11. Frahm J, Bruhn H, Gyngell ML, et al: Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 9:79-93, 1989
12. Galanaud D, Le Fur Y, Nicoli F, et al: Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 13:127-133, 2001
13. Geremia G, Wollman R, Foust R: Computed tomography of gliomatosis cerebri. J Comput Assist Tomogr 12:698-701, 1988
14. Gutowski NJ, Gomez-Anson B, Torpey N, et al: Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology 41:650-653, 1999
15. Hoang-Xuan K, Dairou R, Gray F, et al: Crises d'épilepsie et hémiparésie gauche à répétition. Rev Neurol 158:369-376, 2002
16. Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10:2-12, 1997
17. Lantos PL, Bruner JM: Gliomatosis cerebri, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000, pp 92-93
18. Lev MH: Gliomatosis cerebri has normal relative blood volume: really?! Who cares? Should you? AJNR 23:345-346, 2002
19. Mader I, Roser W, Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4:139-150, 1996
20. Michaelis T, Merboldt KD, Hänicke W, et al: On the identification of cerebral metabolites in localized 1H NMR spectra of the human brain in vivo. NMR Biomed 4:90-98, 1991
21. Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449-458, 1996
22. Peretti-Viton P, Brunel H, Chinot O, et al: Historical and MR correlations in gliomatosis cerebri. J Neurooncol 59:249-259, 2002
23. Pyhtinen J: Proton MR spectroscopy in gliomatosis cerebri. Neuroradiology 42:612-615, 2000
24. Reifenberger G, Kros JM, Burger PC, et al: Oligodendroglioma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000, pp 56-61
25. Salvan AM, Vion-Dury J, Confort-Gouny S, et al: Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32:485-495, 1997
26. Schober R, Mai JK, Volk B, et al: Gliomatosis cerebri: bioptical approach and neuropathological verification. Acta Neurochir 113:131-137, 1991
27. Shin YM, Chang KH, Han MH, et al: Gliomatosis cerebri: comparison of MR and CT features. AJR 161:859-862, 1993
28. Wilken B, Dechent P, Herms J, et al: Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol 23:22-31, 2000
29. Wilson NW, Symon L, Lantos PL: Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. J Neurol 234:445-447, 1987
30. Yang S, Wetzel S, Law M, et al: Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR 23:350-355, 2002
31. Ziegler A, von Kienlin M, Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 61:5595-5600, 2001